Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders
2 other identifiers
interventional
77
1 country
2
Brief Summary
This randomized, controlled effectiveness trial will assess outcomes, implementation, and mechanisms of two psychological treatments for adolescent anorexia nervosa (AN) delivered in the home setting, in the context of community-based mental health. Adolescents with AN-spectrum disorders (n=50) and their caregivers will be randomly assigned to either family-based treatment or integrated family therapy delivered in the home. Caregivers and adolescents will provide data on weight, eating, and putative treatment mechanisms, including caregiver self-efficacy, adolescent distress, and generalizability of treatment skills. Treatment feasibility, acceptability, and appropriateness will be measured among providers and participating families. The proposed study has clear potential to advance scientific and clinical understanding of the real-world effectiveness of psychological treatments for AN, including whether adapting them for the home setting may improve accessibility and effects on treatment outcome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedApril 14, 2026
April 1, 2026
3.7 years
December 1, 2021
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Body mass index percentile
Adolescents will have their height and weight measured to calculate BMI percentile using CDC growth charts and accompanying procedures.
Up to 32-weeks post randomization
Eating Disorder Examination
The Eating Disorder Examination will be used to diagnose anorexia nervosa, and assess eating disorder behaviors, attitudes, and cognitions. Items are scored from 0-7 and averaged to create subscales reflecting restraint, eating concerns, shape concerns, weight concerns, and global eating-related psychopathology. Higher scores indicate more severe eating disorder symptoms.
Up to 32-weeks post randomization
Secondary Outcomes (10)
Abbreviated Acceptability Rating Profile
Up to 32-weeks post randomization
Therapy Suitability and Patient Expectancy
Up to 32-weeks post randomization
Acceptability, Appropriateness, and Feasibility of Intervention Measure
Up to 3 years
Client Satisfaction Questionnaire
Up to 32-weeks post randomization
Multi-theoretical List of Therapeutic Interventions
Up to 32-weeks post randomization
- +5 more secondary outcomes
Other Outcomes (12)
Subjective Units of Distress Scale
Up to 32-weeks post randomization
Parent vs. Anorexia Scale
Up to 32 weeks post-randomization
General Self Efficacy Scale
Up to 32 weeks post-randomization
- +9 more other outcomes
Study Arms (2)
Family-based treatment
EXPERIMENTALFamilies will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care
Integrative family therapy
ACTIVE COMPARATORFamilies will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care
Interventions
FBT is a structured behavioral treatment focused on empowering caregivers to take charge of the adolescent's eating behavior and return him/her to a normative weight and developmental trajectory. FBT involves three consecutive phases: 1) caregivers are fully in control of the adolescent's eating; 2) control of eating is gradually returned to the adolescent; and 3) developmental issues are explored. In the current study, FBT is adapted for delivery in the home setting in the following ways: intensified dose of treatment (2-6 hours of therapy per week over 10 - 32 weeks); use of clinician as an additional support to the family; multiple family meals in the home and community; sociocultural tailoring; and inclusion of supplemental individual work with the adolescent to improve emotion regulation/distress tolerance.
The integrated family therapy approach includes psychoeducation, supportive family therapy, and elements of cognitive-behavioral interventions. Families may be referred for additional nutritional counseling and prescribed a meal plan as indicated. Typical strategies include educating families on the presentation and prognosis of adolescent AN; identifying dysfunctional family structures/alliances and communication patterns; using reflective listening to engage and validate family members; challenging maladaptive beliefs about eating and weight; and supporting families in developing strategies for management of both general and eating disorder-specific distress. Treatment is generally non-directive.
Eligibility Criteria
You may qualify if:
- Meets criteria for AN or atypical AN according to DSM-5 diagnostic criteria.
- Currently living at home with caregivers who are willing to engage in family treatment.
- Medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine (e.g., ≥75% of expected body weight, heartrate ≥50 beats per minute) and receiving medical monitoring from a clinician throughout treatment.
- If on psychotropic medication, meets all eligibility criteria while on stable dose of psychotropic medication for a co-morbid condition.
- Available for follow-up.
You may not qualify if:
- Associated physical illness that necessitates hospitalization.
- Psychotic illness/other mental illness requiring hospitalization.
- Current dependence on drugs or alcohol.
- Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight.
- Concurrent involvement in other psychological treatment for an eating disorder.
- Developmental delay that would preclude participation in the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute of Mental Health (NIMH)collaborator
- Lifespancollaborator
- Rhode Island Collegecollaborator
Study Sites (2)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Gateway Healthcare
Pawtucket, Rhode Island, 02860, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea B Goldschmidt, Ph.D.
The University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 1, 2021
First Posted
January 11, 2022
Study Start
August 1, 2022
Primary Completion
March 30, 2026
Study Completion
April 30, 2026
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- Data will be uploaded at least every 6 months for the duration of the 3-year study.
- Access Criteria
- We will make data and documentation available only under a data-sharing agreement that provides for (1) a commitment to use the data for research purposes only; (2) a commitment to securing the data using appropriate computer technology; (3) a commitment to destroying or returning the data after analyses are completed; and (4) a commitment not to attempt to identify participants individually.
Research data from participants will be shared with the broader scientific community through the NIMH Data Archive and the National Database for Clinical Trials related to Mental Illness. Data will be de-identified and harmonized to a common standard. Data will include all adolescent-, caregiver-, and clinician-level variables reflecting eating- and weight-related outcomes, implementation metrics, and treatment mechanisms, and will be accompanied by a data dictionary describing the variables, data structure, and any relevant coding/re-coding schemes. Data will be uploaded at least every six months for the duration of the study. All informed consent/assent documents will include a discussion of how data will be shared with the Data Archive and the research community.